GENEWATCH
 
Volume 23 Issue 4
 
 
Volume 23 Issue 4
Direct-to-Consumer Genetic Testing
Aug-Sep 2010
 
Lessons Learned: How Berkeley Came to Abruptly Change Its Genetic Testing Program
By Jeremy Gruber
 
Direct-to-Consumer Genetic Testing: What’s the Prognosis?
By Jordan P. Lerner-Ellis, J. David Ellis, Robert Green
 
The Broken Clock: Accuracy and Utility of DTC Tests
By CRG staff - interview with James Evans
 
Consumer Genomics and the Empowered Patient
By Paul Billings
 
Not What the Doctor Ordered
By Sheldon Krimsky
 
DTC Genetic Testing: A UK Perspective
By Helen Wallace
 
False Reassurance
By CRG staff - interview with Adele Schneider
 
In Their Words: 23andMe
By CRG staff - interview with Anne Wojcicki and Ashley Gould
 
Genetic Counselors: Don't Get Tested Without One
By CRG staff - interview with Elizabeth Kearney
 
DTC Genetic Testing: Consumer Privacy Concerns
By Jeremy Gruber
 
The $1,000 Genome: Caveat Emptor
By Andrew D. Thibedeau
 
A View From the Inside
By Nancy Connell
 
DNA Profiling Is Tested in California
By CRG Staff
 
Fishy Business at the FDA
By Eric Hoffman
 
Editorial
By Samuel W. Anderson
 
 
Search: GeneWatch
 
 
 
The purpose of the Genetic Bill of Rights is to introduce a global dialogue on the fundamental values that have been put at risk by new applications of genetics.
 
View Project
 
 
For centuries, human societies have divided population groups into separate races. While there is no scientific basis for this, people unquestioningly accept these classifications as fact.
 
View Project
 
 
Tools
PAGE TOOLS
 
 
 
 
ON THE WEB